IDOVEN is one of the 9 startups selected in the Bridgehead programme.

Bridgehead, a programme that aee entrepreneurs and startups to get in touch with incubators or accelerators that are part of the EIT network. Health, has selected IDOVEN among the 9 Spanish startups selected for Bridgehead Europe.

EIT Healththe main European body for innovation in health, has unveiled this week the startups that will be part of the first call of its Bridgehead programme, in which 9 Spanish projects have been selected, among which is IDOVEN.

This programme has a clear objective: to support European healthcare entrepreneurs who want to expand their business beyond their home market.

The programme, which is called biannually, counts with the participation of 9 Spanish projects, you can see all the participants here. hereout of a total of 30 selected from all over Europe.

IDOVEN is one of the 9 startups selected in the Bridgehead Europe category, with the mission to internationalise their projects at European level, expanding its current focus on Spain and Europe.

The programme Bridgehead programme helps entrepreneurs connect with incubators or accelerators that are part of the EIT Health network. These organisations, known as "catalysts", help startups like IDOVEN to enter markets quickly and decisively.

Thanks to this programme, IDOVEN will be able to help in the early detection of cardiac problems such as myocardial infarction and sudden death by combining Artificial Intelligence algorithms, also outside our borders. You can see more information about our services here.

From EIT Health Spain, its director, Cristina Bescós, comments on the main objective of the Bridgehead programme:

"We are pleased to announce this important project in the healthcare sector. With Bridgehead, we want to promote innovation beyond our borders. We want to help bring new products to new markets, accelerating the adoption of healthcare solutions, services and concepts developed in Spain and across Europe. Ultimately, the programme aims to improve the lives of citizens not only on the European continent, but around the world.

IDOVEN is very proud to be one of the selected startups and we will take advantage of this opportunity.

If you want information about our services you can consult them here

Recent articles

Read All

Idoven raises $19.8 million in funding to redefine detection and precision medicine of cardiovascular diseases with AI

[VIDEO] Manuel Marina, CEO at Idoven, tell you more about our company and the Serie A round

IDOVEN receives €6.5 million of funding from the European Innovation Council